Arcadia Biosciences (NASDAQ:RKDA) Shares Cross Below Fifty Day Moving Average – Here’s Why

Arcadia Biosciences, Inc. (NASDAQ:RKDA) passed below its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $3.81 and traded as low as $3.59. Arcadia Biosciences shares last traded at $3.6190, with a volume of 5,250 shares traded.

Analysts Set New Price Targets

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Arcadia Biosciences in a research note on Monday. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, Arcadia Biosciences currently has an average rating of “Sell”.

Arcadia Biosciences Stock Down 1.1%

The business’s fifty day moving average is $3.81 and its 200 day moving average is $4.11. The stock has a market cap of $4.96 million, a PE ratio of 1.42 and a beta of 0.48.

Arcadia Biosciences (NASDAQ:RKDA) last posted its quarterly earnings results on Friday, November 7th. The basic materials company reported $0.62 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.54) by $1.16. The company had revenue of $1.30 million during the quarter, compared to the consensus estimate of $1.90 million. Arcadia Biosciences had a negative net margin of 97.97% and a negative return on equity of 8.80%.

Arcadia Biosciences Company Profile

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.